National Institute of Allergy and Infectious Diseases

Browse the articles related to this topic below.

Videos

The technological prospects of an effective universal flu vaccine – Milken Institute, C-SPAN

Post author By EvidenceNotFear
Post date 6 October 2021

Aired on C-SPAN on October 29, 2019.

Michael Specter, staff writer for The New Yorker: “Why don’t we blow the system up?”

Health experts discussed the scientific and technological prospects of an effective universal influenza vaccine. Speakers included Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and Margaret Hamburg, former FDA commissioner. Panelists discussed the need for more funding for research, better collaboration between the private and government sectors, advances in technology in flu research and the goal of a universal flu vaccine

http://archive.today/2021.10.05-153300/https://www.c-span.org/video/?465845-1/universal-flu-vaccine

Short clip shared by @R137K:

Full video from the Milken Institute:

Backup mirrors:

Tags C-SPAN, Dr. Fauci, FDA, Influenza, Margaret Hamburg, Milken Institute, mRNA, National Institute of Allergy and Infectious Diseases, USA, Vaccination

News

Revealed: How scientists who dismissed Wuhan lab theory are linked to Chinese researchers – The Telegraph

Post author By EvidenceNotFear
Post date 10 September 2021

All but one scientist who penned a letter in The Lancet dismissing the possibility that coronavirus could have come from a lab in Wuhan were linked to its Chinese researchers, their colleagues or funders, a Telegraph investigation can reveal.

The influential journal published a letter on March 7 last year from 27 scientists in which they stated that they “strongly condemned conspiracy theories” surrounding Covid-19.

http://archive.today/2021.09.10-214838/https://www.telegraph.co.uk/news/2021/09/10/revealed-scientists-dismissed-wuhan-lab-theory-linked-chinese/

Tags Birger Sorensen, Boston University, CDC, Censorship, China, Colorado State University, Cover-up, COVID-19, Curtin University of Technology in Australia, Dr. Charles Calisher, Dr. John Mackenzie, EcoHealth Alliance, Emerging Respiratory Viruses Section, Financial Incentives, George Gao, Global Virome Project, Icahn School of Medicine, Lab Leak, Lancet, Misinformation, National Academy of Sciences, National Institute of Allergy and Infectious Diseases, Ohio State University, Peter Daszak, Professor Angus Dalgleish, Professor Bernard Roizman, Professor Kanta Subbarao, Professor Linda Saif, Professor Peter Palese, Professor Ralph Baric, Professor Richard Ebright, Professor Stanley Perlman, Rutgers University, SAGE, Shi Zhengli, Sir Jeremy Farrar, The Telegraph, The Wellcome Trust, United Nations, University of Iowa, University of London, USA, WHO, Wuhan, Wuhan Institute of Virology

News

The Case for a Coronavirus-Vaccine Bond – The New Yorker

Post author By EvidenceNotFear
Post date 15 August 2020

Drugs are a risky business and, for equity investors hoping to eventually share in the profits, each stage of development presents an escalated risk. Lo reasoned that substantially lowering the risks, even if it meant correspondingly lowering the rewards, could attract investment instead from ordinary bond markets—that is, from managers of pension funds, university endowments, and sovereign-wealth funds, who control a great deal of money and generally invest in low-risk, low-return assets.

Given how uncertain vaccine markets are, the paper notes, governments (“public-sector interventions,” and so forth), would need to guarantee a vaccine bond by committing in advance to purchase and stockpile vaccines. The paper’s most creative suggestion is for a subscription model, a kind of vaccine Netflix, where governments would pay an annual fee to a new international-development fund, one that could perhaps be managed by the G7. The fund could float a bond to both advance vaccine biotechs and to make market commitments to Big Pharma. The virus, the markets, and the science are global.

…it would be much better for the government to say that the money is not from taxpayers. “We’re borrowing it from the rest of the world. And if and when you succeed, or any of the other hundred and fifty projects—that could have been funded, but aren’t being funded right now—succeeds, all the bond holders will get paid. That would be great. Everybody earns a return.”

http://archive.today/2020.08.15-143205/https://www.newyorker.com/news/daily-comment/the-case-for-a-coronavirus-vaccine-bond

Tags AstraZeneca, Banking, BioNTech, Biotechnology, Bird Flu, CEPI, Coalition for Epidemic Preparedness Innovations, COVID-19, Derivatives, Dr. Fauci, European Investment Bank, FDA, Finance, Financial Incentives, Financial Innovation Lab, GAVI Alliance, Government, H5N1, HIV, International Monetary Fund, Johnson & Johnson, Malaria, Merck, MERS, Milbank Memorial Fund, Milken Institute, MIT, Moderna, mRNA, National Institute of Allergy and Infectious Diseases, Neonatal SARS-CoV-2 Viral Load, New York University, Novavax, Oxford Universtity, People’s Bank of China, Pfizer, Pharmaceutical Industry, Philanthropy, Platform, Private-Equity, Research-Backed Obligations, Risk, Social Science Research Network, Software, Subscription, The New Yorker, Trials, Tuberculosis, Vaccine Bonds, WHO, World Bank